About Tata India Service
Agile and safe clinical trials are key to faster drug development
The need to synthesize data from different sources increases the risk of regulatory non-compliance for pharma companies. As a result, they face an exponential increase in clinical research and development costs, sub-optimal clinical trial execution, and delays in launching new, approved drugs. TCS ADD™ enables digital ecosystems, simplifies data complexity, and drives innovation in clinical trials to bring drugs to market faster.
Mission
The manufacturing landscape is undergoing a seismic shift. The future demands a bold new vision – one rooted in the principles of Industry 5.0, where technology drives positive change for people and the planet.
We see this as a pivotal moment for the industry. TATA india service partners with global manufacturing enterprises to navigate this transformation, empowering them to not just adapt, but thrive as future-ready businesses. We harness the transformative power of technologies, like GenAI and quantum computing, to drive meaningful business outcomes and sustainable growth for our clients. We're committed to creating a future where manufacturing ecosystems are resilient, sustainable, and human-centric, leading the way toward a purpose-led and thriving industry.
Meet The Team
The business leaders of today
Jane Doe
Marketing Specialist
John Smith
Brand Strategist
David Brown